Senior Program Officer - Vaccine Delivery @ (October 2008 - January 2012)
Senior Marketing Director @ Merck Vaccine Division (January 2005 - October 2008)
Director of Business Development @ (January 2001 - January 2002)
Project Manager @ (June 1993 - August 1993)
Gerard Cunningham Education
Università degli Studi di Siena
Adjunct Faculty (Module Director - Vaccine Development)
University of Cambridge
M. Eng. (Manufacturing Engineering)
University of Cambridge
M. A. (Engineering)
University of Michigan - Stephen M. Ross School of Business
MBA (International Marketing Strategy)
Gerard Cunningham Skills
Emerging Markets
Strategy
Business Strategy
Product Development
Vaccines
Business Development
Leadership
Pharmaceutical Industry
Infectious Diseases
Healthcare
Mergers & Acquisitions
Marketing
Strategic Communications
Segmentation
Manufacturing
Strategic Planning
International Business
Negotiation
Product Launch
Biotechnology
Executive Management
Market Research
Strategic Partnerships
Start-ups
Commercialization
Analytics
Business Planning
Project Management
Marketing Strategy
Medical Devices
Technology Transfer
Cross-functional Team Leadership
Competitive Analysis
Life Sciences
Cross Functional Team
Sales
Start Ups
Entrepreneurship
Program Management
Cross Functional Team Leadership
Change Management
Customer Service
Project Planning
Mergers and Acquisitions
Gerard Cunningham Summary
Gerard Cunningham, based in Philadelphia, PA, US, is currently a Operating Partner at Adjuvant Capital. Gerard Cunningham brings experience from previous roles at Innovations for Global Health, Merck, Bill & Melinda Gates Foundation and Merck Vaccine Division. Gerard Cunningham holds a Adjunct Faculty in Module Director - Vaccine Development @ Università degli Studi di Siena. With a robust skill set that includes Emerging Markets, Strategy, Business Strategy, Product Development, Vaccines and more. Gerard Cunningham has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Gerard Cunningham?
Find contact details for 700 million professionals.